Delivery Order SPE2DR25D2014-SPE2DR26FA0F3
- Not listed
- The Defense Logistics Agency awarded a $39,167.67 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $18,969.16 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication on December 9, 2025, with completion scheduled for December 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $45,646.15 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price contract with no set-aside designation, competitively awarded to AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of December 18, 2025. The contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle...
- The Defense Logistics Agency awarded a $4,170.02 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of TALTZ 80 mg/mL auto-injector (2-pack). This non-set-aside contract represents a firm fixed price transaction with performance in Conshohocken, Pennsylvania, and is scheduled for completion by September 8, 2025. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $20,092.15 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 23, 2025. The delivery is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under a...
- The Defense Logistics Agency awarded a $15,731.15 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $23,054.25 for TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical product on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $24,951.33 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of TALTZ 80 mg/mL auto-injectors (2-pack). The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. Performance will be completed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of October 27, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,499.42 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on December 17, 2025, with completion scheduled for December 18, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a $4,085.88 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued on December 3, 2025, with an ultimate completion date of December 4, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0F3Delivery Order
The Defense Logistics Agency awarded a $38,985.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of TALTZ 80 mg/mL auto-injector two-packs. The contract, which is not set-aside, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 19, 2025. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant position as a federal medical supply contractor for the Defense Logistics Agency and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order represents a routine transaction within the broader context of the company's substantial IDC with DLA, which supports critical medical commodity needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 12/17/25 |